COMP <GO>
KEYS vs TMO // ENTERPRISE SCALE & MARKET CAP
Keysight Technologies Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: KEYS 5
— TMO 8
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TMO
LAST: $329.84 (-1.69%) • MKT CAP: $56.15B
market-cap
$56.15B
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
market-cap
$262.22B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KEYS VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KEYS | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.50% | 9.30% | +1.20 | KEYS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 57.4x | 30.4x | +27.00 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 2.28% | 2.40% | -0.12 | TMO | /fcf-yield <GO> |
| Operating Margin | 16.30% | 17.40% | -1.10 | TMO | /operating-margins <GO> |
| Net Profit Margin | 15.80% | 15.10% | +0.70 | KEYS | /net-margins <GO> |
| Revenue Growth (YoY) | 8.00% | 3.90% | +4.10 | KEYS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.31 | 4.50 | +3.81 | KEYS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | KEYS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.1 | 62.9 | -16.80 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 0.94 | -0.06 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 61.5x | 36.3x | +25.20 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $56.15B | $262.22B | -$206.06B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KEYS REV | TMO REV | KEYS GROSS % | TMO GROSS % | KEYS FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.38B | $44.56B | 62.1% | — | $1.28B | $6.29B |
| FY 2024 | $4.98B | $42.88B | 62.9% | — | $898.0M | $7.27B |
| FY 2023 | $5.46B | $42.86B | — | — | $1.16B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KEYS // BETA 0.88
TMO // BETA 0.94